These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39267841)

  • 1. A CT-based diagnostic nomogram and survival analysis for differentiating grade 3 pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Hu M; Lv L; Dong H
    Front Oncol; 2024; 14():1443213. PubMed ID: 39267841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 3. MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas.
    Xu J; Yang J; Feng Y; Zhang J; Zhang Y; Chang S; Jin J; Du X
    Front Oncol; 2022; 12():856306. PubMed ID: 35664797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating small (< 2 cm) pancreatic ductal adenocarcinoma from neuroendocrine tumors with multiparametric MRI-based radiomic features.
    Shen K; Su W; Liang C; Shi D; Sun J; Yu R
    Eur Radiol; 2024 Dec; 34(12):7553-7563. PubMed ID: 38869639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of a nomogram model based on CT imaging features in differentiating duodenal gastrointestinal stromal tumors from pancreatic head neuroendocrine tumors.
    Yan W; Yu H; Xu C; Zeng M; Wang M
    Abdom Radiol (NY); 2024 Sep; ():. PubMed ID: 39302444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features.
    Shen X; Yang F; Jiang T; Zheng Z; Chen Y; Tan C; Ke N; Qiu J; Liu X; Zhang H; Wang X
    Eur J Radiol; 2024 Feb; 171():111284. PubMed ID: 38232572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
    Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
    Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
    Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
    Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases.
    Arima K; Okabe H; Hashimoto D; Chikamoto A; Tsuji A; Yamamura K; Kitano Y; Inoue R; Kaida T; Higashi T; Taki K; Imai K; Komohara Y; Beppu T; Takeya M; Baba H
    Int J Clin Oncol; 2016 Oct; 21(5):940-945. PubMed ID: 27023215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a Nomogram to Preoperatively Predict Distant Metastasis of Pancreatic Neuroendocrine Tumor in Elderly Patients.
    Li G; Bing YT; Tian ML; Yuan CH; Xiu DR
    Chin Med Sci J; 2021 Sep; 36(3):218-224. PubMed ID: 34666875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis.
    Ren S; Qian L; Daniels MJ; Duan S; Chen R; Wang Z
    Eur J Radiol; 2020 Dec; 133():109360. PubMed ID: 33126171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.